FTSE 100 news / Companies and sectors / Smith & Nephew / 1 October 2026
Smith & Nephew (SN): news on Thursday 1 October 2026
+2.0 slightly positive
Coverage mixed a new EVOS PELVIC trauma system launch and reported first-half growth of 4.60 percent with a piece on scrutiny over leadership and debt headlines. The positive product and growth news is partly offset by that concern.
What drove it
- EVOS PELVIC launch
- first-half growth
- leadership and debt scrutiny
The 3 stories
- +7.5 Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
New trauma product launch supports its orthopaedics portfolio. - +6.7 Smith & Nephew stock reports 4.60 percent H1 growth
Reports first-half growth of 4.60 percent. - −6.3 What Is Keeping FTSE 100 Medtech Smith & Nephew Under Scrutiny As Leadership And Debt Headlines Build?
Scrutiny over leadership and debt headlines weighs on reputation.
Smith & Nephew: every day · Pharma and healthcare on 1 October 2026 · FTSE 100 overview for the day